Philips Acquires Intact Vascular

Royal Philips Acquires Vesper Medical from Gilde Healthcare

December 14, 2021

Medical Devices

Royal Philips has signed an agreement to acquire Vesper Medical Inc., a US-based maker of minimally-invasive peripheral venous stent devices and a portfolio company of Gilde Healthcare. The acquisition will add Vesper's DUO Venous Stent System to Philips' image-guided therapy and peripheral vascular portfolio; the deal is expected to close in Q1 2022 and includes roughly 20 Vesper employees joining Philips.

Philips Acquires Analytical Informatics, Inc.

November 24, 2017

Healthcare Services

Royal Philips has acquired US-based startup Analytical Informatics, Inc. to integrate the company's vendor-agnostic radiology workflow and analytics tools into Philips' PerformanceBridge radiology portfolio. The acquisition is intended to accelerate Philips' roadmap for Radiology Solutions by expanding operational intelligence, workflow optimization and data-driven decision support for imaging departments and enterprise customers; financial terms were not disclosed.

ICU Medical Acquires Pursuit Vascular

November 4, 2019

Medical Devices

ICU Medical, Inc. agreed to acquire Pursuit Vascular, Inc. for $75 million plus a potential earnout, bringing the ClearGuard HD antimicrobial catheter cap into ICU Medical’s consumables portfolio. The acquisition expands ICU Medical’s infection-prevention product offerings and distribution channels (domestic and international); Pursuit Vascular’s 2019 revenue was an estimated $10–12 million.

Royal Philips Acquires Capsule Technologies from Francisco Partners for $635M

January 19, 2021

Medical Devices

Royal Philips agreed to acquire Capsule Technologies, a portfolio company of Francisco Partners, for $635 million in cash. The deal will fold Capsule — a developer of medical device integration, patient monitoring, and clinical surveillance software used by hospitals worldwide — into Philips' Connected Care segment; Capsule has roughly 300 employees and serves more than 2,800 hospitals in 40 countries.

Abbott Acquires Cardiovascular Systems, Inc.

February 8, 2023

Medical Devices

Abbott has agreed to acquire Cardiovascular Systems, Inc. (CSI) for $20.00 per share, representing an expected equity value of approximately $890 million. The acquisition adds CSI's orbital atherectomy system and early-stage vascular intervention pipeline to Abbott's vascular device portfolio to expand its capabilities in treating peripheral and coronary artery disease.

Royal Philips to Acquire BioTelemetry, Inc. for $2.8B

December 18, 2020

Healthcare Services

Royal Philips has agreed to acquire BioTelemetry, Inc. in a cash tender offer of USD 72.00 per share, implying an enterprise value of approximately USD 2.8 billion. The deal combines Philips' hospital patient-monitoring capabilities with BioTelemetry's remote cardiac diagnostics and monitoring services (which serve over 1 million patients annually and had 2019 sales of about USD 439 million) to expand Philips' patient care management offerings across hospital and home settings.